Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

One of the promised benefits of 'personalised' medicine is that it will have a positive impact on disease screening and prevention, by enabling more person-specific estimates of risk, and hence more personalised strategies for screening and risk reduction. This article summarises some of the areas in which these approaches are already being implemented, but also outlines some of the potential difficulties and limitations - and challenges the assumption that 'personalised' approaches are necessarily superior for prevention and screening.

Original publication

DOI

10.1080/20502877.2017.1314884

Type

Journal article

Journal

New Bioeth

Publication Date

04/2017

Volume

23

Pages

21 - 29

Keywords

epidemiology, genetic testing, personalised medicine, prevention, risk reduction, screening